Expert Opinion on Therapeutic Patents, Volume 29, Issue 7 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Patents, Volume 29, Issue 7 (2019)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Volume 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patent Evaluation

Article
Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho & Lourdes Millán-Pérez Peña
Pages: 481-485
Published online: 21 Jun 2019
AbstractforCancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1 | Full Text | References | PDF (705 KB) | EPUB
  • 235 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review
A literature review of the patent publications on venetoclax – a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent
Nina Žigart & Zdenko Časar
Pages: 487-496
Published online: 07 Jun 2019
AbstractforA literature review of the patent publications on venetoclax – a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent | Full Text | References | PDF (1.1 MB) | EPUB
  • 885 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
mGluR2 positive allosteric modulators: an updated patent review (2013–2018)
Andrés A Trabanco, José Manuel Bartolomé & José María Cid
Pages: 497-507
Published online: 04 Jul 2019
AbstractformGluR2 positive allosteric modulators: an updated patent review (2013–2018) | Full Text | References | PDF (1.7 MB) | EPUB
  • 635 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Carbonic anhydrases as disease markers
Sabina Zamanova, Ahmed M Shabana, Utpal K Mondal & Marc A Ilies
Pages: 509-533
Published online: 17 Jun 2019
AbstractforCarbonic anhydrases as disease markers | Full Text | References | PDF (1.8 MB) | EPUB
  • 438 Views
  • 41 CrossRef citations
  • 0Altmetric
Review
Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018)
Hidayat Hussain, Ghulam Abbas, Ivan R. Green & Iftikhar Ali
Pages: 535-553
Published online: 26 Jun 2019
AbstractforDipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018) | Full Text | References | PDF (3.2 MB) | EPUB
  • 345 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications
L Crocetti, MT Quinn, IA Schepetkin & MP Giovannoni
Pages: 555-578
Published online: 16 Jun 2019
AbstractforA patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications | Full Text | References | PDF (5.3 MB) | EPUB
  • 505 Views
  • 43 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Pages: 579-585
Published online: 04 Jul 2019
First Page PreviewforCorrection | Full Text | PDF (465.1 KB) | EPUB
  • 505 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

An updated patent review on PD-1/PD-L1 antagonists (2022-present)
Wiktor Uzar et al.
Review Article | Published online: 21 Jun 2024
Protein tyrosine phosphatase inhibitors: a patent review and update (2012–2023)
Lakshmi Mounika Kelam et al.
Review Article | Published online: 19 Jun 2024
A patent review on hypoxia-inducible factor (HIF) modulators (2021–2023)
Jiaming Liu et al.
Review Article | Published online: 19 Jun 2024
Recent advances in the development of P2Y14R inhibitors: a patent and literature review (2018-present)
Kai Wang et al.
Review Article | Published online: 19 Jun 2024
View all latest articles